جست‌وجوی استاد و پژوهشگر

Maria Golsonمشاهده پروفایل

استادیار

• Endocrinology
• Beta-cell Function
• Insulin Secretion
• +۶ مورد دیگر

Maria Golson, PhD, is an Assistant Professor of Medicine in the Division of Endocrinology, Obesity and Metabolism at the Johns Hopkins School of Medicine. She joined the institution in 2020 and leads research focused on the intrinsic and extrinsic regulation of beta-cell function and insulin secretion. Her work is central to understanding pancreatic endocrine cell development and its implications in diabetes. Education: B.S. in Biology (Genetics concentration), Duke University, 2000 Ph.D. in Cell and Molecular Biology (Genetics and Gene Regulation), University of Pennsylvania, 2008 Postdoctoral Training, Vanderbilt University Dr. Golson's research spans molecular mechanisms of beta-cell function, epigenetic regulation in diabetes, and single-cell analysis of pancreatic islets. She employs advanced genomic and epigenomic tools to explore cellular states in both type 1 and type 2 diabetes, with a focus on identifying pathways that could be targeted for regeneration or functional enhancement of insulin-producing cells. Her recent publications, appearing in journals such as Nature Metabolism and Diabetes , reflect a strong trend toward multiomics and single-cell technologies to uncover novel cellular states in human islets. These studies integrate transcriptomics, epigenetics, and functional validation to dissect disease mechanisms. Dr. Golson has been supported by institutional affiliations and collaborations, including membership in the HPAP Consortium and the American Diabetes Association. While no formal awards are listed, her publication record indicates significant scientific contributions. She has mentored researchers through collaborative projects, though no formal advisees are named. Her lab engages in interdisciplinary research involving genetics, molecular biology, and bioinformatics to advance diabetes therapeutics.

• Neuroscience
• Stem Cell Biology
• Neurodevelopment
• +۳ مورد دیگر

Suel-Kee Kim is an Associate Research Scientist in Neuroscience at the Yale School of Medicine, Yale University. Their research focuses on neurodevelopment, stem cell biology, and cellular mechanisms underlying neurological disorders. Key areas include neural fate determination from pluripotent stem cells, molecular programs in macaque brain development, and transcriptomic analysis of neural differentiation pathways. Notable contributions include studies on cellular recovery post-ischemia, impaired neurogenesis in congenital hydrocephalus, and retinoic acid's role in prefrontal cortex patterning. Collaborations with leading labs like the Sestan Lab emphasize interdisciplinary approaches in neuroscience and regenerative medicine. Publications highlight innovative work in stem cell microenvironment engineering, forensic transcriptomics of flies, and pancreatic islet differentiation for diabetes therapy. Their research bridges basic science and translational applications in neurology and regenerative medicine.

Rana K. Guptaمشاهده پروفایل

استاد

• Adipose tissue biology
• Energy homeostasis
• Obesity and metabolic disease
• +۵ مورد دیگر

Rana K. Gupta, PhD , is the W. David and Sarah W. Stedman Distinguished Professor of Medicine and Cell Biology at Duke University School of Medicine and serves as Section Chair of Basic Sciences within the Duke Molecular Physiology Institute . Previously, he spent ten years on the faculty at the University of Texas Southwestern Medical Center. His laboratory investigates the developmental biology and molecular regulation of adipose tissue, with the goal of translating insights into therapies for obesity and metabolic diseases. Education & Training: PhD, University of Pennsylvania (2006) Research Fellow, Dana-Farber Cancer Institute, Cell Biology (2006–2012) Research Interests: Dr. Gupta’s work centers on two inter-related themes: (1) the transcriptional networks that establish and maintain white, brown, and beige adipocyte lineages, with a spotlight on the zinc-finger factor ZFP423 ; and (2) the heterogeneity and functional specialization of adipocyte progenitor cells during healthy versus pathological adipose-tissue expansion. Using single-cell multi-omics, lineage tracing, and metabolic phenotyping in mice and humans, his team deciphers how distinct progenitor pools orchestrate adipogenesis, angiogenesis, and immune remodeling in obesity. Key Publications: Across 78 peer-reviewed papers (2010-2025), Dr. Gupta has defined ZFP423 as a molecular brake on adipocyte thermogenesis, uncovered PDGFRβ+ progenitor subpopulations that drive hyperplastic adipose growth, and demonstrated that inducible Zfp423 deletion can convert white adipocytes into energy-burning beige cells to reverse diet-induced obesity. Recent single-cell atlases further reveal sex- and depot-dependent progenitor heterogeneity, providing a roadmap for targeted metabolic therapies. Scientific Awards & Honors: W. David and Sarah W. Stedman Distinguished Professorship Funding & Training Leadership: Principal Investigator on 13 active NIH, ADA, and foundation grants (2021-2029) Director, Endocrinology and Metabolism Training Program (NIDDK T32) Co-Investigator, Medical Scientist Training Program (NIGMS T32) Mentor to 6 postdocs, 4 graduate students, and numerous undergraduates and research technicians Lab Teams & Collaborations: The Gupta Lab at Duke is a multi-disciplinary team of postdoctoral fellows (Pablo Morales, Wenxin Tong), graduate students (Ashley Truong), instructors (Jessica Cannavino), and research analysts (Krissy Campbell, Lavanya Vishvanath) collaborating closely with the Duke Molecular Physiology Institute to integrate genomics, physiology, and translational medicine.

Timothy D. O'Brienمشاهده پروفایل

استاد

• Veterinary Pathology
• Comparative Pathology
• Transplantation Biology
• +۴ مورد دیگر

Timothy D. O'Brien is a Professor and Division Head of Comparative Pathology in the Department of Veterinary Population Medicine at the University of Minnesota College of Veterinary Medicine. He holds multiple affiliations including the Stem Cell Institute, Masonic Cancer Center, and Institute for Engineering in Medicine. Dr. O'Brien also serves as faculty for the Masters Program in Stem Cell Biology. Dr. O'Brien earned his BS, DVM, and PhD degrees from the University of Minnesota in 1976, 1978, and 1985 respectively. He is a Diplomate of the American College of Veterinary Pathologists (Anatomic Pathology, 1984). His research spans veterinary pathology, transplantation biology, stem cell research, and cancer biology with a focus on comparative pathology models. He has made significant contributions to understanding interspecies organogenesis, islet xenotransplantation, and animal models for human diseases. His work bridges veterinary and human medicine, exploring translational applications of findings from animal models to human conditions. Recent publications highlight innovative approaches to transplantation without long-term immunosuppression and studies on hemangiosarcoma biology. Dr. O'Brien's publication record demonstrates expertise across multiple disciplines including diabetes research using feline models, lung cancer heterogeneity, and innovative transplantation techniques. His work frequently involves interdisciplinary collaborations across veterinary medicine, engineering, and human medical specialties, reflecting the integrative nature of modern biomedical research. His research program involves extensive collaborations across the University of Minnesota and beyond, working on projects related to stem cell biology, cancer research, and transplantation medicine. As Division Head of Comparative Pathology, he oversees diagnostic pathology services while maintaining an active research program that contributes to advancing our understanding of disease mechanisms through comparative approaches.

• RNA Biology
• Genomics
• Transcriptomics
• +۵ مورد دیگر

Dr. Athma A Pai is an Associate Professor at UMass Chan Medical School, holding primary appointments in the RNA Therapeutics Institute and the T.H. Chan School of Medicine. She maintains extensive secondary appointments across multiple departments including Genomics and Computational Biology, Systems Biology, and several graduate programs at the Morningside Graduate School of Biomedical Sciences, reflecting the highly interdisciplinary nature of her work. Education: BS in Biochemistry/Anthropology from University of Pennsylvania PhD in Human Genetics from University of Chicago Postdoctoral training in RNA Genomics from MIT Dr. Pai's research program centers on RNA biology with particular emphasis on RNA processing, splicing mechanisms, and the regulation of gene expression. Her work investigates how environmental factors influence RNA processing through biochemical, molecular, and genetic mechanisms. She employs cutting-edge genomic and transcriptomic approaches to study alternative polyadenylation, mRNA transcript initiation and termination, and the spatial organization of RNA processing events within cells. Her research has significant implications for understanding fundamental gene regulation mechanisms and their roles in disease processes. Analysis of Dr. Pai's recent publications reveals a strong focus on developing high-resolution profiling methods for understanding transcriptional and translational regulation. Her work increasingly integrates computational approaches with experimental biology to investigate how RNA processing events are coordinated across the transcriptome. A notable trend is her exploration of how RNA processing contributes to inflammatory responses and cellular defense mechanisms, with implications for therapeutic development. Dr. Pai actively mentors students through multiple graduate programs at UMass Chan Medical School, including Biochemistry and Molecular Biotechnology, Biophysical Chemical and Computational Biology, Interdisciplinary Graduate Program, MD/PhD Program, RNA Therapeutics and Biology Program, and Systems Computational and Quantitative Biology. She maintains an active laboratory (Pai Lab) that welcomes postdoctoral researchers interested in RNA biology. Her laboratory website provides additional information about ongoing research projects and opportunities for collaboration and training, and she maintains a professional presence through her Twitter account (@athmapai).

• Diabetes Research
• Pancreatic Islet Physiology
• Insulin Secretion
• +۳ مورد دیگر

Patrik Rorsman is a Professor of Diabetic Medicine at the University of Oxford, affiliated with Harris Manchester College and the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM). His research focuses on pancreatic islet physiology, particularly the regulation of insulin and glucagon secretion in health and diabetes. He leads a multidisciplinary group studying cellular mechanisms underlying hormone secretion, including metabolic signaling, ion channel function, and intercellular communication within islets. Key research interests include α-cell and δ-cell function, electrical coupling between islet cells, and the pathophysiological defects in diabetes. Notable contributions include discoveries on glucagon regulation by AVP, nicotinic signaling, and somatostatin receptor antagonists. His team employs advanced electrophysiology, imaging, and stem cell models to explore therapeutic targets for diabetes. Awards: Fellow of the Royal Society (FRS) and Fellow of the Academy of Medical Sciences (FMedSci). Grants/Funding: Supported by Wellcome Trust, Diabetes UK, JDRF, and MRC. Collaborations: Prof Frances Ashcroft, Prof Antony Galione, Prof Bernard Thorens. Current projects include investigating α-cell heterogeneity, optogenetic control of δ-cells, and clinical trials (e.g., LEGEND-A study). The Rorsman Group also trains PhD candidates and postdoctoral researchers, emphasizing translational research to improve diabetes treatment.

• Diabetes
• Cardiovascular Outcomes
• Diabetic Nephropathy
• +۵ مورد دیگر

Professor Steve Bain is a Professor in Medicine (Diabetes) at Swansea University, affiliated with the School of Biomedical Sciences and the Swansea University Medical School. He holds dual roles as Assistant Medical Director for Research & Development at Swansea Bay University Health Board and Clinical Director of the Diabetes Research Unit. His career spans academic research, clinical practice, and healthcare policy. Prof. Bain completed his undergraduate studies at St John's College, Cambridge, and clinical training at King's College Hospital, London. He has held academic positions at the University of Birmingham (Reader in Diabetic Medicine) before moving to Swansea in 2005 as a Chair in Medicine. His clinical expertise includes diabetes management, nephropathy, and novel therapies. Research interests focus on diabetes genetics, cardiovascular outcomes, and kidney disease. He leads multi-center trials (e.g., ONWARDS, SOUL) and chairs the ILS Joint Clinical Research Facility Board. Awards include Fellowship of the Royal College of Physicians (1996). He advises national bodies like the UK Human Genetics Commission and contributes to guidelines (e.g., ABCD-UKKA kidney disease management). His teaching includes leading the Diabetes Practice Masters program and courses on diabetes epidemiology and therapeutics.

John S. Kaddisمشاهده پروفایل

دانشیار

• Type 1 Diabetes
• Systems Biology
• Bioinformatics
• +۵ مورد دیگر

John S. Kaddis, Ph.D. is an Associate Professor in the Department of Diabetes & Cancer Discovery Science within the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope. With over 15 years of experience at City of Hope, Dr. Kaddis has developed scientific resources for team-based research initiatives focused on type 1 diabetes, creating data systems, analysis tools, and websites used by researchers worldwide. Dr. Kaddis earned his B.S. (Honors) in Biochemistry from California State University Los Angeles, where he completed undergraduate research supported by two National Science Foundation fellowships. He later earned his Ph.D. in Systems Biology and Disease from the University of Southern California. His academic journey includes positions as Assistant Professor since 2015 and Associate Professor since 2022 at City of Hope. Dr. Kaddis's research primarily focuses on the complex mechanisms of type 1 diabetes through systems biology and bioinformatics approaches. His work centers on understanding islet cell biology, beta cell dysfunction, and the immunological aspects of type 1 diabetes. His research has evolved from developing collaborative data resources to conducting cutting-edge investigations into genetic factors in diabetes pathogenesis. He has pioneered the creation of bioinformatics platforms that enable global collaboration in diabetes research. The trends in Dr. Kaddis's publications reveal a progression from foundational work on biobanking and data management toward increasingly sophisticated investigations of genetic and immunological mechanisms in type 1 diabetes. His recent work emphasizes translational applications, including potential therapeutic strategies and predictive models that span diverse ancestral backgrounds. His research bridges basic science with clinical applications through the Human Islet Research Network. Member, American Association for the Advancement of Science (2011-Present) Professional Member, American Diabetes Association (2010-Present) Member, Society of Clinical Research Associates (2003-2012) Lifetime Member, Tri-Beta Honor Society (2000-Present) Dr. Kaddis serves as principal investigator and co-investigator on multiple NIH and JDRF-funded projects, including the Human Islet Research Network Bioinformatics Center and the JDRF nPOD DataShare initiative. His work has established critical infrastructure for collaborative diabetes research, enabling researchers worldwide to access and analyze complex datasets. His laboratory has developed specialized data management systems that facilitate the sharing of islet cell research data across international boundaries while maintaining appropriate security and privacy protections. Dr. Kaddis's athletic pursuits in marathons and triathlons mirror his research approach—requiring stamina and perseverance to achieve long-term goals in diabetes research.

Fatima AlZahra'a Alatraktchiمشاهده پروفایل

دانشیار

• Biomarkers
• Electrochemical Analysis
• Prostate Cancer Diagnostics
• +۵ مورد دیگر

Fatima AlZahra'a Alatraktchi is an Associate Professor at Roskilde University's Department of Science and Environment. Her research focuses on biomarker detection, electrochemical analysis, and biomedical sensor development, with applications in prostate cancer diagnostics, pregnancy hormone monitoring, and microbial pathogen detection. She is affiliated with the Molecular and Medical Biology Centre for Mathematical Modeling – Human Health and Disease. Key research interests include nanotechnology-driven biosensors, urinary biomarkers for disease staging, and the development of point-of-care diagnostic tools. She has pioneered rapid electrochemical methods for detecting pathogens like Pseudomonas aeruginosa and has contributed to improving early-stage cancer detection through amino acid profiling. Alatraktchi leads the project Investigating the role of neurotransmitters in pancreatic development and islet cell function (2024–2027), combining 4D bioimaging with neurotransmitter sensing. Her work has been featured in 53 media outlets, addressing topics like gender representation in STEM and school-based health testing solutions. Notable awards include the 2019 Forbes 30 Under 30, 2017 Lundbeck Foundation Talent Prize, and 2019 PhD of the Year Award. Her research has produced 36 peer-reviewed publications and one patent, emphasizing translational applications in healthcare technology.

Randy J. Seeleyمشاهده پروفایل

استاد

• Neuroscience
• Endocrinology
• Nutritional Sciences
• +۴ مورد دیگر

Randy J. Seeley is the Henry K. Ransom Endowed Professor of Surgery at the University of Michigan School of Medicine, with adjunct appointments in Internal Medicine and Nutritional Sciences. His research focuses on central nervous system regulation of energy balance, obesity, diabetes, and metabolic disease interventions. His scientific work explores how peripheral hormones interact with the CNS to control food intake, body weight, and fuel metabolism. Recent studies highlight innovative approaches including GLP-1 receptor agonists, bariatric surgery mechanisms, and gut-liver-brain axis interactions. Publications span top journals like Nature , Science , and Cell Metabolism , emphasizing translational research from animal models to human metabolic outcomes. Key themes include hormonal signaling, weight-loss maintenance, and metabolic inflammation. 2009 Outstanding Scientific Achievement Award (American Diabetes Association) 2022 AAAS Fellow Dr. Seeley has served on NIH review panels and the Science editorial board, advancing obesity and diabetes research through interdisciplinary collaborations.

Gordon W. Laurieمشاهده پروفایل

استاد

• Cell Biology
• Ocular Biology
• Dry Eye Disease
• +۵ مورد دیگر

Gordon W. Laurie is a Professor in the Department of Cell Biology at the University of Virginia School of Medicine. His research focuses on epithelial homeostasis, secretion, and innate defense mechanisms, with particular emphasis on the human prosecretory mitogen 'lacritin' that his lab discovered. Dr. Laurie's work has translational applications for dry eye disease, the most common eye condition, and he co-founded TearSolutions, Inc. in 2013 to advance therapeutic development. Dr. Laurie received his academic training with a BS in Biology from McMaster University MS in Cell Biology from McGill University PhD in Cell Biology from McGill University Dr. Laurie's research program centers on lacritin, a protein critical for ocular surface homeostasis and innate defense. His lab discovered that lacritin and its cleavage-potentiated fragments contribute to tear film stability and exhibit bactericidal properties. Current research directions include identifying lacritin's signaling receptor, exploring its effects on iPSC-derived sensory neurons, investigating its bactericidal activity, and examining potential benefits for pancreatic islet function in type 1 diabetes. His work bridges basic science with clinical applications, particularly for dry eye disease. The publication record demonstrates consistent research productivity with a strong focus on ocular surface biology, lacritin function, and autophagy mechanisms in eye health. Recent work shows increasing clinical translation, including phase 2 clinical trials for dry eye treatment, while maintaining fundamental investigations into molecular mechanisms. Collaborative research with institutions worldwide represents a hallmark of Dr. Laurie's scientific approach. Dr. Laurie organized the multi-institutional Lacritin Consortium in 2002, which has continued to meet biannually with participating institutions including UVa, James Madison University, Eastern Virginia Medical School, Harvard University, University of Illinois at Chicago, Johns Hopkins, UCSF, UC-Berkeley, and the US Army at Fort Belvoir. This collaborative network has been instrumental in advancing understanding of lacritin biology and its therapeutic potential.

Todd R. Evansمشاهده پروفایل

استاد

• Developmental Biology
• Stem Cell Research
• Cardiac Development
• +۵ مورد دیگر

Todd R. Evans is a Professor at Weill Cornell Medicine with appointments in the Department of Cell and Developmental Biology. His research program bridges developmental biology, stem cell science, and disease modeling, with particular focus on cardiac development, diabetes research, and organoid systems. Dr. Evans maintains active collaborations across multiple institutions and serves as Principal Investigator on several NIH-funded research projects. Dr. Evans' research focuses on the molecular mechanisms governing embryonic development, particularly in cardiac and pancreatic systems. His laboratory investigates transcription factor networks (especially GATA factors), signaling pathways (WNT, BMP, NODAL), and epigenetic regulation during organ formation. Developmental mechanisms of heart formation Stem cell differentiation into functional organ systems Organoid models for disease research Transcriptional and epigenetic regulation during development Diabetes pathogenesis and beta cell biology Analysis of Dr. Evans' recent publications reveals a strong emphasis on using human pluripotent stem cells and organoid models to investigate developmental processes and disease mechanisms. His work increasingly integrates CRISPR-based screening, chemical biology approaches, and advanced imaging techniques to dissect molecular pathways in cardiac and pancreatic development. A notable trend is the application of these models to study viral pathogenesis (particularly SARS-CoV-2) and immune-mediated tissue damage. Dr. Evans' research has been recognized through substantial federal funding and high-impact publications, with several papers receiving over 100 citations. Notable work includes foundational studies on GATA transcription factors in development and innovative organoid models for studying diabetes and viral infections. Dr. Evans serves as Principal Investigator on multiple NIH grants, including projects funded by the National Heart, Lung, & Blood Institute and the National Institute of Child Health & Human Development. His laboratory has trained numerous graduate students and postdoctoral fellows who have gone on to successful careers in academia and industry. Current research directions include the development of novel organoid systems and the application of chemical biology approaches to manipulate stem cell differentiation. Dr. Evans leads a multidisciplinary research team that includes developmental biologists, stem cell experts, and computational biologists. His laboratory maintains state-of-the-art facilities for stem cell culture, organoid development, and advanced microscopy, supporting collaborative projects across Weill Cornell Medicine and with external partners.

Julie Sneddonمشاهده پروفایل

دانشیار

• Stem Cell Biology
• Developmental Biology
• Genomics
• +۳ مورد دیگر

Julie Sneddon, PhD, is an Associate Professor in the Department of Cell and Tissue Biology at the University of California San Francisco (UCSF). Her research focuses on pancreatic development and Type I Diabetes, employing stem cell biology, developmental biology, genomics, and tissue engineering to understand cellular microenvironment dynamics. Her laboratory investigates non-epithelial 'niche' cell types in the pancreas to advance regenerative medicine approaches for replacing lost cell and organ function. Research Interests: Dr. Sneddon’s work centers on the cellular and molecular mechanisms underlying pancreatic organogenesis, adult organ function, and disease. Key areas include stem cell niche biology, single-cell analysis of developing tissues, and bioengineering strategies for cell encapsulation and transplantation. Her studies aim to bridge basic science with clinical applications in diabetes treatment and regenerative medicine. Articles Overview: Dr. Sneddon’s publications span topics such as pancreatic developmental genetics, stem cell differentiation, and engineered biomaterials for cell-based therapies. Her work emphasizes multi-omics approaches (e.g., chromatin accessibility, single-cell transcriptomics) to map cell state transitions and gene regulatory networks in developing organs. Labs/Teams: The Sneddon Lab integrates molecular biology, genomics, and bioengineering to address pancreatic biology challenges. Collaborations span UCSF’s Diabetes Center, Tissue Engineering groups, and industry partners in regenerative medicine.

• Diabetes
• Endocrinology
• Islet Transplantation
• +۳ مورد دیگر

David M. Harlan is a Professor of Medicine at UMass Chan Medical School and Chief of Diabetes at UMass Memorial Medical Center. He serves as Co-Director of the Diabetes Center of Excellence and holds multiple faculty appointments across the T.H. Chan School of Medicine in departments including Medicine , Pediatrics , and RNA Therapeutics Institute . Education: BS in Physiology from University of Michigan MD from Duke University Research Interests focus on: Islet transplantation and tolerance mechanisms Autoimmune diabetes (Type 1) pathogenesis Human beta cell biology and regeneration Diabetes care delivery systems Immunomodulation in transplantation Translational diabetes research Recent Publications highlight expertise in diabetes immunology, islet transplantation, and gene editing technologies, with notable work on HSV-1's role in autoimmune diseases and prime editing efficiency in beta cells. His research spans clinical trials, animal models, and human islet biology. Clinical Trials & Grants include NIH-funded studies on diabetes therapies and collaborations in islet transplantation protocols.

• Nutrition
• Functional Foods
• Gut-Skin Axis
• +۱۳ مورد دیگر

Emilia Borba Alves is an Assistant Professor at Lusófona University, School of Health Sciences and Technologies, where she has been teaching since 2014. She also serves as the Director of the Master in Clinical Nutrition program since 2023. She is affiliated with CBIOS, the Research Center in Biosciences and Technologies at Lusófona University, where she leads research on functional foods and human health. Her academic background spans engineering, nutrition, and management. Education: Ph.D. in Health Sciences (Nutrition), Universidad de Alcalá, Spain (2022) Postgraduate in Metabolic Diseases and Eating Behavior, Faculty of Medicine, University of Lisbon (2013) Degree in Nutrition Sciences, Atlantic University (2013) Post-graduation in Management, Nova School of Business and Economics (2003) Degree in Chemical Engineering, Instituto Superior Técnico, University of Lisbon (1992) Advanced Training: Clinical Trial Monitoring, Food Metabolites & Microbiota, Professional Update Course on Nutrition in Pregnancy Her research focuses on nutrition, functional foods, gut-skin axis, microbiota, and metabolic diseases , with a particular emphasis on kefir and probiotics . She investigates how fermented foods influence skin health, diabetes, and overall metabolic function. Her work bridges clinical nutrition, food science, and public health. The recent publications highlight a strong trend in fermented foods, gut-skin interactions, diabetes pathophysiology, and nutritional counseling . Many studies use human trials to assess kefir’s impact on skin hydration, atopic dermatitis, and microbial balance. Her work also extends to pharmacist roles in nutrition, teacher knowledge, and public health literacy, showing a multidisciplinary approach to improving nutritional outcomes. Scientific Awards: No awards explicitly mentioned in the text. She has advised or supervised students in the Bachelor and Master’s programs in Nutrition, Pharmaceutical Sciences, and Health Products. She has been involved in research grants through CBIOS, though specific grant names are not listed. Her leadership in the Master’s program indicates active academic mentorship and curriculum development. She is a member of CBIOS (Research Center in Biosciences and Technologies) at Lusófona University, where she conducts studies on the impact of functional foods on human health and disease. Her team likely includes researchers focused on food science, microbiology, and clinical nutrition, particularly in the area of fermented products and their systemic effects.